Actym Therapeutics
Bacterial intelligence engineered to deliver unprecedented solutions in medicine.
Actym Therapeutics was founded in 2017, is headquartered in Berkeley, United States, lists 11–50 employees, and has $59.5M in recorded funding across 2 rounds.
- Headquarters
- Berkeley, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- actymthera.com
- Total Funding
- $59.5M
- Last Round
- $25.5M Series AOct 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Actym Therapeutics is a Berkeley, California-based clinical-stage biotechnology company developing engineered bacterial therapeutics for cancer and fibrotic disease. Its STACT (S. Typhimurium Anti-Cancer Therapy) platform uses a precisely engineered, systemically administered bacterial vehicle to deliver multiple therapeutic payloads directly and exclusively to the tumor microenvironment, where they are locally amplified to produce therapeutic effects while avoiding systemic toxicity. The lead program, ACTM-838, delivers a constitutively active STING agonist (eSTING) and IL-15plex into tumor-resident myeloid cells to convert immunologically cold tumors to hot, enabling robust engagement of both innate and adaptive immunity. ACTM-838 is currently being evaluated in a Phase 1a/1b clinical trial in patients with advanced solid tumors.
Summary
Actym Therapeutics is a Biotech company based in Berkeley, United States, founded in 2017. It lists 11–50 employees. It has raised $59.5M in total across 2 rounds, most recently a $25.5M Series A round in Oct 2023. Investors include Boehringer Ingelheim Venture Fund, Illumina Ventures and Korea Investment Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2023
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/actym-therapeutics"><img src="https://indexed.vc/api/badge/company/actym-therapeutics" alt="Actym Therapeutics on Indexed.vc" width="260" height="76" /></a>